The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology

J Transl Med. 2024 Mar 15;22(1):279. doi: 10.1186/s12967-024-05087-w.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Peptides / pharmacology
  • Peptides / therapeutic use

Substances

  • Peptides